Early prediction of menopausal status after chemotherapy in women with early breast cancer in order to optimize adjuvant endocrine therapy by Charissa van Zwol-Janssens, Mandy M. van Rosmalen, Esther Oomen-de Hoop, Jan C. Drooger, Annemieke van der Padt-Pruijsten, Hanneke J.M. Zuetenhorst, Yvonne V. Louwers, Jenny A. Visser, Joop S.E. Laven, Agnes Jager

Get full text

Motion based ex vivo (MOTEX) culture of breast tumor slices sustains microenvironment composition by Zofia M. Komar, Mieke Bavelaar, Ellen Kageler, Nicole S. Verkaik, Mandy M. van Rosmalen, Carolien H.M. van Deurzen, Michael A. den Bakker, Roland Kanaar, Adriaan B Houtsmuller, Thierry P.P. van den Bosch, Agnes Jager, Dik C. van Gent

Get full text

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre... by Niels A.D. Guchelaar, Ron H.J. Mathijssen, Maaike de Boer, Marlies L. van Bekkum, Joan B. Heijns, Birgit E.P.J. Vriens, Mandy M. van Rosmalen, Lonneke W. Kessels, Lisanne Hamming, Karin J. Beelen, Peter Nieboer, Susan M. van den Berg, Esther Oomen-de Hoop, Rhodé M. Bijlsma, Monique E.M.M. Bos

Get full text